170 related articles for article (PubMed ID: 2242301)
1. Modulation of mammalian O6-alkylguanine-DNA alkyltransferase in vivo by O6-benzylguanine and its effect on the sensitivity of a human glioma tumor to 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea.
Dolan ME; Stine L; Mitchell RB; Moschel RC; Pegg AE
Cancer Commun; 1990; 2(11):371-7. PubMed ID: 2242301
[TBL] [Abstract][Full Text] [Related]
2. Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents.
Dolan ME; Moschel RC; Pegg AE
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5368-72. PubMed ID: 2164681
[TBL] [Abstract][Full Text] [Related]
3. Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Felker GM; Friedman HS; Dolan ME; Moschel RC; Schold C
Cancer Chemother Pharmacol; 1993; 32(6):471-6. PubMed ID: 8258196
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the inactivation of mammalian and bacterial O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine and O6-methylguanine.
Dolan ME; Pegg AE; Dumenco LL; Moschel RC; Gerson SL
Carcinogenesis; 1991 Dec; 12(12):2305-9. PubMed ID: 1747932
[TBL] [Abstract][Full Text] [Related]
5. Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents.
Dolan ME; Mitchell RB; Mummert C; Moschel RC; Pegg AE
Cancer Res; 1991 Jul; 51(13):3367-72. PubMed ID: 1647266
[TBL] [Abstract][Full Text] [Related]
6. Effect of O6-benzylguanine on the sensitivity of human colon tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).
Dolan ME; Pegg AE; Moschel RC; Grindey GB
Biochem Pharmacol; 1993 Jul; 46(2):285-90. PubMed ID: 8347150
[TBL] [Abstract][Full Text] [Related]
7. Depletion of O6-alkylguanine-DNA alkyltransferase by O6-benzylguanine in three-dimensional collagen cultures of normal human breast epithelial cells.
Hamdan MA; Guzman RC; Yang J; Beattie C; Mascharack P; Nandi S
Carcinogenesis; 1992 Oct; 13(10):1743-9. PubMed ID: 1423833
[TBL] [Abstract][Full Text] [Related]
8. Effect of O6-benzylguanine on the response to 1,3-bis(2-chloroethyl)-1-nitrosourea in the Dunning R3327G model of prostatic cancer.
Dolan ME; Pegg AE; Biser ND; Moschel RC; English HF
Cancer Chemother Pharmacol; 1993; 32(3):221-5. PubMed ID: 8500228
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme.
Friedman HS; Dolan ME; Moschel RC; Pegg AE; Felker GM; Rich J; Bigner DD; Schold SC
J Natl Cancer Inst; 1992 Dec; 84(24):1926-31. PubMed ID: 1334154
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of O6-benzylguanine, an inactivator of O6-alkylguanine-DNA alkyltransferase.
Dolan ME; Chae MY; Pegg AE; Mullen JH; Friedman HS; Moschel RC
Cancer Res; 1994 Oct; 54(19):5123-30. PubMed ID: 7923129
[TBL] [Abstract][Full Text] [Related]
11. Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation.
Mitchell RB; Moschel RC; Dolan ME
Cancer Res; 1992 Mar; 52(5):1171-5. PubMed ID: 1737376
[TBL] [Abstract][Full Text] [Related]
12. Synergistic efficacy of O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in a human colon cancer xenograft completely resistant to BCNU alone.
Gerson SL; Zborowska E; Norton K; Gordon NH; Willson JK
Biochem Pharmacol; 1993 Jan; 45(2):483-91. PubMed ID: 8435098
[TBL] [Abstract][Full Text] [Related]
13. Depletion of O6-alkylguanine-DNA alkyltransferase activity in mammalian tissues and human tumor xenografts in nude mice by treatment with O6-methylguanine.
Dolan ME; Larkin GL; English HF; Pegg AE
Cancer Chemother Pharmacol; 1989; 25(2):103-8. PubMed ID: 2557168
[TBL] [Abstract][Full Text] [Related]
14. Resistance of the human O6-alkylguanine-DNA alkyltransferase containing arginine at codon 160 to inactivation by O6-benzylguanine.
Edara S; Kanugula S; Goodtzova K; Pegg AE
Cancer Res; 1996 Dec; 56(24):5571-5. PubMed ID: 8971155
[TBL] [Abstract][Full Text] [Related]
15. Phase I clinical trial of O6-benzylguanine and topical carmustine in the treatment of cutaneous T-cell lymphoma, mycosis fungoides type.
Apisarnthanarax N; Wood GS; Stevens SR; Carlson S; Chan DV; Liu L; Szabo SK; Fu P; Gilliam AC; Gerson SL; Remick SC; Cooper KD
Arch Dermatol; 2012 May; 148(5):613-20. PubMed ID: 22250189
[TBL] [Abstract][Full Text] [Related]
16. Point mutations in human O6-alkylguanine-DNA alkyltransferase prevent the sensitization by O6-benzylguanine to killing by N,N'-bis (2-chloroethyl)-N-nitrosourea.
Loktionova NA; Pegg AE
Cancer Res; 1996 Apr; 56(7):1578-83. PubMed ID: 8603405
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of inactivation of human O6-alkylguanine-DNA alkyltransferase by O6-benzylguanine.
Pegg AE; Boosalis M; Samson L; Moschel RC; Byers TL; Swenn K; Dolan ME
Biochemistry; 1993 Nov; 32(45):11998-2006. PubMed ID: 8218276
[TBL] [Abstract][Full Text] [Related]
18. O6-Alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea.
Brent TP; Houghton PJ; Houghton JA
Proc Natl Acad Sci U S A; 1985 May; 82(9):2985-9. PubMed ID: 3857628
[TBL] [Abstract][Full Text] [Related]
19. Effects of inhibition of O6-alkylguanine-DNA alkyltransferase in rats on carcinogenesis by methylnitrosourea and ethylnitrosourea.
Lijinsky W; Pegg AE; Anver MR; Moschel RC
Jpn J Cancer Res; 1994 Mar; 85(3):226-30. PubMed ID: 8188519
[TBL] [Abstract][Full Text] [Related]
20. Modulation of O6-methylguanine-DNA methyltransferase-mediated 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea resistance by O6-benzylguanine in vitro and in vivo.
Chen JM; Zhang YP; Sui JL; Moschel RC; Ikenaga M
Anticancer Res; 1993; 13(3):801-5. PubMed ID: 8317915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
